Recent studies have begun to elucidate the role of NAT10 (N-acetyltransferase 10)-mediated ac4C modifications in various physiological and pathological processes [17], particularly in neurodegenerative diseases [18]. This evidence concerns the gene NAT10 and neurodegenerative disease.